高级检索
当前位置: 首页 > 详情页

Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究参与人:
研究单位: [1]Peking Union Medical College Hospital [2]Beijing Tongren Hospital [3]Chinese Academy of Medical Sciences,Fuwai Hospital [4]The Luhe Teaching Hospital of the Capital Medical University [5]The Seventh Affiliated Hospital of Sun Yat-sen University [6]First Affiliated Hospital of Xinjiang Medical University [7]Nanyang Nanshi Hospital of Henan University [8]Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

关键词: Rituximab cyclosporine idiopathic membranous nephropathy

研究目的:
The primary objective of this study is to determine whether or not cyclosporine (CsA) combined with RTX is more effective than RTX alone in the treatment of idiopathic membranous nephropathy (iMN).

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)